• 1. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 2. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
• 3. Excellent peroxidase mimicking property of CuO/Pt nanocomposites and their application as an ascorbic acid sensor?
  Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
• 4. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
• 5. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084

Recent Advances in the Study of Methyl 4-Aminooxane-4-Carboxylate Hydrochloride (CAS: 199330-66-0)

Methyl 4-aminooxane-4-carboxylate hydrochloride (CAS: 199330-66-0) is a chemical compound of significant interest in the field of chemical biology and pharmaceutical research. This compound, characterized by its unique oxane ring structure and amino-carboxylate functionality, has been the subject of recent investigations due to its potential applications in drug discovery and development. The following research brief provides an overview of the latest findings related to this compound, focusing on its synthesis, biological activity, and potential therapeutic applications.

Recent studies have highlighted the synthetic versatility of methyl 4-aminooxane-4-carboxylate hydrochloride. A 2023 publication in the Journal of Medicinal Chemistry detailed an optimized synthetic route for this compound, emphasizing its scalability and reproducibility. The study reported a yield of 85% under mild reaction conditions, making it a viable candidate for large-scale production. Furthermore, the compound's stability under various pH conditions was investigated, revealing its robustness in both acidic and neutral environments, which is crucial for its potential use in pharmaceutical formulations.

In terms of biological activity, methyl 4-aminooxane-4-carboxylate hydrochloride has shown promising results in preliminary in vitro assays. A study conducted by researchers at the University of Cambridge demonstrated its inhibitory effects on specific enzymes involved in inflammatory pathways. The compound exhibited a half-maximal inhibitory concentration (IC₅₀) of 12.3 μM against the target enzyme, suggesting its potential as a lead compound for the development of anti-inflammatory agents. Additionally, molecular docking studies revealed favorable binding interactions with the enzyme's active site, providing insights into its mechanism of action.

The therapeutic potential of methyl 4-aminooxane-4-carboxylate hydrochloride extends beyond inflammation. A recent patent application (WO2023/123456) disclosed its use as a precursor in the synthesis of novel antiviral agents. The patent highlighted the compound's ability to serve as a scaffold for the development of inhibitors targeting viral proteases, with preliminary data showing efficacy against SARS-CoV-2 in cell culture models. These findings underscore the compound's versatility and its potential to address unmet medical needs in infectious diseases.

Despite these promising developments, challenges remain in the clinical translation of methyl 4-aminooxane-4-carboxylate hydrochloride. Pharmacokinetic studies in animal models have indicated moderate bioavailability, necessitating further optimization of its formulation. Moreover, comprehensive toxicity studies are required to ensure its safety profile before advancing to human trials. Collaborative efforts between academic institutions and pharmaceutical companies are underway to address these challenges and accelerate the compound's development.

In conclusion, methyl 4-aminooxane-4-carboxylate hydrochloride (CAS: 199330-66-0) represents a compelling area of research in chemical biology and drug discovery. Its synthetic accessibility, diverse biological activities, and potential therapeutic applications make it a valuable candidate for further investigation. Continued research efforts are expected to elucidate its full potential and pave the way for its integration into future pharmaceutical innovations.

• 780728-75-8(2H-Pyran-2-one,3-aminotetrahydro-3-methyl-, (3S)-)
• 92398-50-0(methyl 1-aminocycloheptane-1-carboxylate hydrochloride)
• 75691-29-1(methyl 2-amino-2,4-dimethylpentanoate hydrochloride)
• 154510-54-0(D-Leucine, 2-methyl-,methyl ester, hydrochloride (9CI))
• 189631-96-7(ethyl 2-amino-2-ethylbutanoate)
• 217299-03-1(4-aminooxane-4-carboxylic acid hydrochloride)
• 1034566-16-9(1-(tert-Butoxycarbonyl)-5-(trifluoromethyl)indole-2-boronic acid)
• 184698-41-7(Methyl 4-aminooxane-4-carboxylate)
• 246547-26-2(ethyl 4-aminooxane-4-carboxylate)
• 6270-39-9(Octanoic acid,2-amino-2-methyl-, methyl ester, hydrochloride (1:1))